Year |
Citation |
Score |
2011 |
Kong MM, Verma V, O'Dowd BF, George SR. The role of palmitoylation in directing dopamine D1 receptor internalization through selective endocytic routes. Biochemical and Biophysical Research Communications. 405: 445-9. PMID 21241663 DOI: 10.1016/J.Bbrc.2011.01.050 |
0.583 |
|
2010 |
Verma V, Hasbi A, O'Dowd BF, George SR. Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2. The Journal of Biological Chemistry. 285: 35092-103. PMID 20807772 DOI: 10.1074/Jbc.M109.088625 |
0.613 |
|
2010 |
Mann A, Verma V, Basu D, Skoblenick KJ, Beyaert MG, Fisher A, Thomas N, Johnson RL, Mishra RK. Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: evidence for the allosteric modulation of the dopamine receptor. European Journal of Pharmacology. 641: 96-101. PMID 20639138 DOI: 10.1016/J.Ejphar.2010.05.018 |
0.346 |
|
2009 |
So CH, Verma V, Alijaniaram M, Cheng R, Rashid AJ, O'Dowd BF, George SR. Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Molecular Pharmacology. 75: 843-54. PMID 19171671 DOI: 10.1124/Mol.108.051805 |
0.594 |
|
2007 |
Rashid AJ, O'Dowd BF, Verma V, George SR. Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine. Trends in Pharmacological Sciences. 28: 551-5. PMID 17950471 DOI: 10.1016/J.Tips.2007.10.001 |
0.493 |
|
2007 |
So CH, Verma V, O'Dowd BF, George SR. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor. Molecular Pharmacology. 72: 450-62. PMID 17519357 DOI: 10.1124/Mol.107.034884 |
0.6 |
|
2005 |
Verma V, Mann A, Costain W, Pontoriero G, Castellano JM, Skoblenick K, Gupta SK, Pristupa Z, Niznik HB, Johnson RL, Nair VD, Mishra RK. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog. The Journal of Pharmacology and Experimental Therapeutics. 315: 1228-36. PMID 16126839 DOI: 10.1124/Jpet.105.091256 |
0.413 |
|
Show low-probability matches. |